Sharp Financial Services’s Novo Nordisk NVO Stock Holding History

Sharp Financial Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Buy	+5,900	New	+$253K	0.13%	107
2026 Q1	–	Sell	-7,600	Closed	-$387K	–	126
2025 Q4	$387K	Buy	7,600 +1,600	+27%	+$81.8K	0.19%	75
2025 Q3	$333K	Buy	6,000 +2,700	+82%	+$158K	0.18%	77
2025 Q2	$228K	Sell	3,300 -200	-6%	-$13.6K	0.15%	78
2025 Q1	$243K	Buy	3,500 +600	+21%	+$49.6K	0.19%	80
2024 Q4	$249K	Sell	2,900 -2,675	-48%	-$289K	0.19%	82
2024 Q3	$664K	Buy	5,575 +3,575	+179%	+$477K	0.51%	34
2024 Q2	$285K	Buy	+2,000	New	+$265K	0.24%	76

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sharp Financial Services's NVO Position: Q2 2026 in Review

Sharp Financial Services opened a new position in Novo Nordisk (NVO) in Q2 2026: 5,900 shares worth $283K. The stake represents 0.13% of the portfolio and ranks #107 among its holdings. This is a return to the name: Sharp Financial Services previously reported a position in NVO as recently as Q4 2025.

Sharp Financial Services first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $664K in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Sharp Financial Services held 5,900 shares of Novo Nordisk worth $283K as of Q2 2026.
Novo Nordisk was a new Sharp Financial Services position in Q2 2026.
Novo Nordisk made up 0.13% of Sharp Financial Services's portfolio in Q2 2026, its #107 holding.
Sharp Financial Services first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
Sharp Financial Services's Novo Nordisk position peaked at $664K in Q3 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sharp Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.